Recall Atlas
Drugs & medicalClass II

Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46…

Presence of particulate matter - Glass like particles.

Read the official notice →
Date
2026-01-14
Country
United States
Brand
Imprimis NJOF
Product
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46…
Classification
Class II
Units
U.S Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Imprimis NJOF recalls

  1. 2025-11-26
  2. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL…

    Subpotent Drug

    FDA · DrugImprimis NJOF, LLCUSA nationwideOfficial notice →
  3. 2025-07-30
  4. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only,…

    Sub-Potent Drug: Subpotent assay results during stability testing.

    FDA · DrugImprimis NJOF, LLCNationwide in the USAOfficial notice →
  5. 2025-04-09
  6. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis…

    Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.

    FDA · DrugImprimis NJOF, LLCFL and NYOfficial notice →
  7. 2024-06-19
  8. US
    Drugs & medicalClass II

    Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis…

    Lack of Assurance of Sterility

    FDA · DrugImprimis NJOF, LLCUS NationwideOfficial notice →
  9. 2024-06-05
  10. US
    Drugs & medicalClass II

    Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular…

    Lack of Assurance of Sterility

    FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →
  11. 2024-05-08
  12. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46…

    Out of specification for assay

    FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →
All 11 Imprimis NJOF recalls →

Other drugs & medical recalls in the United States

  1. 2026-01-14
  2. US
    Drugs & medicalClass I

    Medinatura New Mexico, inc. recalls ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE,…

    Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.

    FDA · DrugMedinatura New Mexico, inc.Nationwide in the USOfficial notice →
  3. US
    Drugs & medicalClass II

    SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

    Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

    FDA · DrugSpecGx, LLCNationwideOfficial notice →
  4. US
    Drugs & medicalClass II

    Signature Formulations, LLC recalls ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USA

    cGMP Deviations

    FDA · DrugSignature Formulations, LLCAZ onlyOfficial notice →
  5. US
    Drugs & medicalClass III

    Alembic Pharmaceuticals Limited recalls Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited,…

    Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

    FDA · DrugAlembic Pharmaceuticals LimitedUS Nationwide and PR.Official notice →
  6. 2026-01-07
  7. US
    Drugs & medicalClass II

    Beaver-Visitec International, Inc. recalls BVI Leos Laser and Endoscopy System. Model Number: OME6000U.

    Manufacturing deviation in which the ferrites specified for the USB cable assembly linking the Nurse Monitor touchscreen to the System Controller were not installed as intended. The omission of the ferrites on the USB…

    FDA · DeviceBeaver-Visitec International, Inc.US Nationwide distribution in the states of FL, MI, OK, TX, WI.Official notice →
  8. US
    Drugs & medicalClass II

    Philips Ultrasound, LLC recalls Philips EPIQ Ultrasound Systems (various models) used in conjunction with the X5-1c transducer REF: , , 795200, 795201, 795231, 795232,…

    Retroactive: Ultrasound may experience an unexpected automatic reboot, resulting in damage to transducer.

    FDA · DevicePhilips Ultrasound, LLCWorldwide - US Nationwide distribution in the states of AK, AL, AR, AZ, CA,…Official notice →
See all drugs & medical recalls →